Zobrazeno 1 - 10
of 25
pro vyhledávání: '"KATHLEEN M. DUNGAN"'
Publikováno v:
AACE Clinical Case Reports, Vol 1, Iss 3, Pp e194-e198 (2015)
ABSTRACT: Objective: Earlier cases have documented a discrepancy between glycated hemoglobin A1c (HbA1C) levels and glycemic control in patients with diabetes and previously diagnosed hereditary spherocytosis (HS). However, this has not been reported
Externí odkaz:
https://doaj.org/article/aa3e01b8fd534821ac137d5b570bf18e
Autor:
Eileen R. Faulds, Kathleen M. Dungan, Molly McNett, Laureen Jones, Norma Poindexter, Matthew Exline, Jillian Pattison, Francisco J. Pasquel
Publikováno v:
Journal of Diabetes Science and Technology. 17:649-655
Background: The COVID-19 pandemic necessitated rapid implementation of continuous glucose monitoring (CGM) in the intensive care unit (ICU). Although rarely reported, perceptions from nursing staff who used the systems are critical for successful imp
Publikováno v:
Current Diabetes Reports. 23:69-87
Publikováno v:
Diabetes spectrum : a publication of the American Diabetes Association. 35(4)
The use of diabetes technology, including insulin pumps, continuous glucose monitoring devices, and automated insulin delivery systems, has increased significantly in recent years. As more people with diabetes adopt technology in the outpatient setti
Autor:
Audrey White, Elizabeth Buschur, Cara Harris, Michael L Pennell, Adam Soliman, Kathleen Wyne, Kathleen M Dungan
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 15:2323-2334
Audrey White,1 Elizabeth Buschur,2 Cara Harris,2 Michael L Pennell,3 Adam Soliman,2 Kathleen Wyne,2 Kathleen M Dungan2 1Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA; 2Division of Endocrinology, Diab
Autor:
Kathleen M. Dungan, Lars Bardtrum, Erik Christiansen, Johanna Eliasson, Linda Mellbin, Vincent C. Woo, Tina Vilsbøll
Publikováno v:
Diabetes Therapy.
Introduction A post hoc analysis of the PIONEER 1–5 and 8 trials assessed the clinically relevant composite endpoints of HbA1c (glycated haemoglobin) reduction ≥ 1% and body weight loss of ≥ 5% or ≥ 10% with orally administered semaglutide ve
Autor:
Kathleen M, Dungan, Phil A, Hart, Dana K, Andersen, Marina, Basina, Vernon M, Chinchilli, Kirstie K, Danielson, Carmella, Evans-Molina, Mark O, Goodarzi, Carla J, Greenbaum, Rita R, Kalyani, Maren R, Laughlin, Ariana, Pichardo-Lowden, Richard E, Pratley, Jose, Serrano, Emily K, Sims, Cate, Speake, Dhiraj, Yadav, Melena D, Bellin, Frederico G S, Toledo
Publikováno v:
Pancreas
OBJECTIVES: The metabolic abnormalities that lead to diabetes mellitus (DM) following an episode of acute pancreatitis (AP) have not been extensively studied. This manuscript describes the objectives, hypotheses, and methods of mechanistic studies of
Autor:
Phil A, Hart, Georgios I, Papachristou, Walter G, Park, Anne-Marie, Dyer, Vernon M, Chinchilli, Elham, Afghani, Venkata S, Akshintala, Dana K, Andersen, James L, Buxbaum, Darwin L, Conwell, Kathleen M, Dungan, Jeffrey J, Easler, Evan L, Fogel, Carla J, Greenbaum, Rita R, Kalyani, Murray, Korc, Richard, Kozarek, Maren R, Laughlin, Peter J, Lee, Jennifer L, Maranki, Stephen J, Pandol, Anna Evans, Phillips, Jose, Serrano, Vikesh K, Singh, Cate, Speake, Temel, Tirkes, Frederico G S, Toledo, Guru, Trikudanathan, Santhi Swaroop, Vege, Ming, Wang, Cemal, Yazici, Atif, Zaheer, Christopher E, Forsmark, Melena D, Bellin, Dhiraj, Yadav
Publikováno v:
Pancreas
Acute pancreatitis (AP) is a disease characterized by an acute inflammatory phase followed by a convalescent phase. Diabetes mellitus (DM) was historically felt to be a transient phenomenon related to acute inflammation; however, it is increasingly r
Autor:
Kathleen M. Dungan
Publikováno v:
Diabetes Care. 45:2204-2206
Autor:
JILLIAN PATTISON, KATHLEEN M. DUNGAN, ELIZABETH BUSCHUR, MATTHEW C. EXLINE, LAUREEN G. JONES, CASEY MAY, MOLLY MCNETT, KEATON SMETANA, EILEEN R. FAULDS
Publikováno v:
Diabetes. 71
The coronavirus disease 2019 pandemic resulted in the need for remote glucose monitoring in intensive care unit (ICU) patients requiring insulin infusions. While rarely reported, perceptions from nursing staff are critical for successful implementati